SEC Form 4 · accession 0001628280-16-014054
SCYNEXIS INC · SCYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gonzalez David Angulo
Officer — Chief Medical Officer
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.05 | Apr 1, 2016 | A | 70,000 | A | — | Mar 31, 2026 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F12.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant.